Jonathan Block

creativica/iStock via Getty Images The UK's Medicines and Healthcare products Regulatory Agency has approved Novartis' ( NVS ) Rhapsido (remibrutinib) for chronic spontaneous urticaria.

filo Doximity ( DOCS ) is up ~64% in after-hours trading Thursday after boosting its fiscal year 2027 revenue guidance range.

Chip Somodevilla/Getty Images News President Trump is considering issuing an executive order—possibly as soon as next week—on vaccines and autism as he is apparently growing frustrated with a lack of action on the topic.

Izzet Esmece/iStock via Getty Images The US FDA has granted accelerated approval to Replimune's ( REPL ) gene therapy Tudriqev (v usolimogene

jurgenfr Although ResMed ( RMD ) reported fiscal 2026 Q4 results after Thursday's closing bell that beat on both lines, the stock is

filo Ardelyx ( ARDX ) is down ~13% in Friday morning trading after lowering full-year revenue expectations for its irritable bowel syndrome treatment Ibsrela (tenapanor).

Morgan Stanley upgrades Roche to overweight, boosting PT to $63 on giredestrant and trontinemab catalysts. Read more here.

angelp The US FDA's M olecular and Clinical Genetics Panel of the Medical Devices Advisory Committee will meet on Sept. 23 to offer its view on GRAIL's ( GRAL ) Galleri multi-cancer early detection test.

An FDA advisory panel on Sept. 23 will review GRAIL’s Galleri multi-cancer blood test. Read more here.

miodrag ignjatovic/iStock via Getty Images AbCellera Biologics ( ABCL ) is up ~8% in after-hours trading following an announcement it will